Institution
University of Zambia
Education•Lusaka, Lusaka, Zambia•
About: University of Zambia is a education organization based out in Lusaka, Lusaka, Zambia. It is known for research contribution in the topics: Population & Health care. The organization has 2593 authors who have published 4402 publications receiving 122411 citations. The organization is also known as: UNZA.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: The feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing at primary-care health-care facilities in southern Africa, and the primary outcome was tuberculosis-related morbidity in culture-positive patients who had begun anti-tuberculosis treatment.
392 citations
••
University of Alabama at Birmingham1, Centre for Infectious Disease Research in Zambia2, Aga Khan University3, University of Zambia4, RTI International5, University of Missouri–Kansas City6, Drexel University7, Tulane University8, University of North Carolina at Chapel Hill9, University of Colorado Denver10, University of Maryland, Baltimore11, National Institutes of Health12
TL;DR: The rate of neonatal death in the 7 days after birth did not decrease after the introduction of Essential Newborn Care training of community-based birth attendants, although the rate of stillbirths was reduced.
Abstract: Background Of the 37 million neonatal deaths and 33 million stillbirths each year, 98% occur in developing countries An evaluation of community-based interventions designed to reduce the number of these deaths is needed Methods With the use of a train-the-trainer model, local instructors trained birth attendants from rural communities in six countries (Argentina, Democratic Republic of Congo, Guatemala, India, Pakistan, and Zambia) in the World Health Organization Essential Newborn Care course (which focuses on routine neonatal care, resuscitation, thermoregulation, breast-feeding, “kangaroo” [skin-to-skin] care, care of the small baby, and common illnesses) and (except in Argentina) in a modified version of the American Academy of Pediatrics Neonatal Resuscitation Program (which teaches basic resuscitation in depth) The Essential Newborn Care intervention was assessed among 57,643 infants with the use of a before-and-after design The Neonatal Resuscitation Program intervention was assessed as a cluster-randomized, controlled trial involving 62,366 infants The primary outcome was neonatal death in the first 7 days after birth Results The 7-day follow-up rate was 992% After birth attendants were trained in the Essential Newborn Care course, there was no significant reduction from baseline in the rate of neonatal death from all causes in the 7 days after birth (relative risk with training, 099; 95% confidence interval [CI], 081 to 122) or in the rate of perinatal death; there was a significant reduction in the rate of stillbirth (relative risk with training, 069; 95% CI, 054 to 088; P = 0003) In clusters of births in which attendants had been randomly assigned to receive training in the Neonatal Resuscitation Program, as compared with control clusters, there was no reduction in the rates of neonatal death in the 7 days after birth, stillbirth, or perinatal death Conclusions The rate of neonatal death in the 7 days after birth did not decrease after the introduction of Essential Newborn Care training of community-based birth attendants, although the rate of stillbirths was reduced Subsequent training in the Neonatal Resuscitation Program did not significantly reduce the mortality rates (ClinicalTrials gov number, NCT00136708)
379 citations
••
TL;DR: A simple, standardized tuberculosis screening rule for resource-constrained settings is reported, to identify people living with HIV who need further investigation for TB disease.
Abstract: Background: The World Health Organization recommends the screening of all people living with HIV for tuberculosis (TB) disease, followed by TB treatment, or isoniazid preventive therapy (IPT) when TB is excluded. However, the difficulty of reliably excluding TB disease has severely limited TB screening and IPT uptake in resource-limited settings. We conducted an individual participant data meta-analysis of primary studies, aiming to identify a sensitive TB screening rule. Methods and Findings: We identified 12 studies that had systematically collected sputum specimens regardless of signs or symptoms, at least one mycobacterial culture, clinical symptoms, and HIV and TB disease status. Bivariate random-effects meta-analysis and the hierarchical summary relative operating characteristic curves were used to evaluate the screening performance of all combinations of variables of interest. TB disease was diagnosed in 557 (5.8%) of 9,626 people living with HIV. The primary analysis included 8,148 people living with HIV who could be evaluated on five symptoms from nine of the 12 studies. The median age was 34 years. The best performing rule was the presence of any one of: current cough (any duration), fever, night sweats, or weight loss. The overall sensitivity of this rule was 78.9% (95% confidence interval [CI] 58.3%–90.9%) and specificity was 49.6% (95% CI 29.2%–70.1%). Its sensitivity increased to 90.1% (95% CI 76.3%–96.2%) among participants selected from clinical settings and to 88.0% (95% CI 76.1%–94.4%) among those who were not previously screened for TB. Negative predictive value was 97.7% (95% CI 97.4%–98.0%) and 90.0% (95% CI 88.6%–91.3%) at 5% and 20% prevalence of TB among people living with HIV, respectively. Abnormal chest radiographic findings increased the sensitivity of the rule by 11.7% (90.6% versus 78.9%) with a reduction of specificity by 10.7% (49.6% versus 38.9%). Conclusions: Absence of all of current cough, fever, night sweats, and weight loss can identify a subset of people living with HIV who have a very low probability of having TB disease. A simplified screening rule using any one of these symptoms can be used in resource-constrained settings to identify people living with HIV in need of further diagnostic assessment for TB. Use of this algorithm should result in earlier TB diagnosis and treatment, and should allow for substantial scale-up of IPT. Please see later in the article for the Editors’ Summary.
375 citations
••
TL;DR: The results suggest that children of all ages with clinical features of HIV infection should receive co-trimoxazole prophylaxis in resource-poor settings, irrespective of local resistance to this drug.
368 citations
••
TL;DR: A 3-day course of nitazoxanide significantly improved the resolution of diarrhoea, parasitological eradication, and mortality in HIV-seronegative, but not HIV-Seropositive, children.
367 citations
Authors
Showing all 2635 results
Name | H-index | Papers | Citations |
---|---|---|---|
Alimuddin Zumla | 100 | 747 | 43284 |
David Clark | 73 | 652 | 24857 |
Sten H. Vermund | 69 | 606 | 22181 |
Paul A. Kelly | 68 | 208 | 16836 |
Francis Drobniewski | 67 | 293 | 17371 |
Ayato Takada | 67 | 273 | 14467 |
Karl Peltzer | 60 | 880 | 18515 |
Hirofumi Sawa | 55 | 325 | 11735 |
Peter Godfrey-Faussett | 52 | 173 | 8486 |
Igor J. Koralnik | 52 | 197 | 10186 |
Peter Mwaba | 48 | 132 | 7386 |
Alison M. Elliott | 48 | 299 | 7772 |
Kelly Chibale | 47 | 337 | 7713 |
Chihiro Sugimoto | 47 | 325 | 7737 |
Sian Floyd | 47 | 163 | 6791 |